Management of high-risk gestational trophoblastic disease - The memorial hospital experience

International Journal of Gynecological Cancer

Volumn 7, Issue 1, 1997, Pages 27-33

  Jones, W B ^a,b   Cardinale, C ^a   Lewis Jr , J L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Academic Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; HYDROXYUREA; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; PACLITAXEL; VINCRISTINE SULFATE;

ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; PREDICTION; PRIORITY JOURNAL; REMISSION; SURVIVAL RATE; TREATMENT OUTCOME; TROPHOBLASTIC DISEASE;

EID: 0031022577     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00409.x     Document Type: Article

References (33)

1. Ross GT, Goldstein DP, Hertz R, Lipsett MB, Odell WD. Sequential use of methotrexate and actinomycin-D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in women. Am J Obstet Gynecol 1965; 93: 223-9.
2. Hammond CB, Parker RT. Diagnosis and treatment of trophoblastic disease. A report from the Southeastern Regional Center. Obstet Gynecol 1970; 35: 132-43.
3. Hammond CB, Borchert LG, Tyrey L, Creasman WT, Parker RT. Treatment of metastatic trphoblastic disease: good and poor prognosis. Am J Obstet Gynecol 1973; 115: 451-7.
4. Bagshawe KD. Treatment of trophoblastic tumours. Recent results. Cancer Res 1977; 62: 192-9.
5. WHO Scientific Group (1982) Gestational Trophoblastic Disease. World Health Organization, Geneva: 692.
6. Lewis JL Jr. Treatment of metastatic trophoblastic neoplasms. Am J Obstet Gynecol 1979; 136: 163-72.
7. Jones WB, Lewis JL Jr, Lehr M. Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the beta-subunit of human chorionic gonadotropin. Am J Obstet Gynecol 1975; 121: 669-73.
8. DuBeshter B, Berkowitz RS, Goldstein DP, Cramer DW, Bernstein MR. Metastatic Gestational Trophoblastic Disease: Experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol 1987; 69: 390-5.
9. Surwit EA. Management of high-risk gestational trophoblastic disease. J Reprod Med 1987; 32, 657-662.
10. Surwit EA, Hammond CB. Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol 1980; 55: 565-70.
11. Berkowitz RS, Goldstein DP. Modified triple chemotherapy. In: Szulman AE, Buchsbaum HJ, eds. Gestational Trophoblastic Disease. New York: Springer-Verlag, 1987: 146-54.
12. Gordon AN, Gershenson DM, Copeland LJ, Saul PB, Kavanagh JJ, Edwards CL. High-risk metastatic gestational trophoblastic disease. Obstet Gynecol 1985; 65: 550-6.
13. Lurain JR, Brewer JI. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy. Obstet Gynecol 1985; 65: 830-6.
14. Curry SL, Blessing JA, DiSaia PJ, Soper JT, Twiggs LB. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, melphalan, hydroxyurea, and vincristine in 'poor prognosis' metastatic gestational trophoblastic disease: A gynecologic oncology group study. Obstet Gynecol 1989; 73: 357-62.
15. Soper JT, Evans AC, Conway MR, Clarke-Pearson DL, Berchuck A, Hammond CB. Evaluation of prognositic factors and staging in gestational trophoblastic tumor. Obstet Gynecol 1994; 84: 969-73.
16. Newlands ES, Bagshawe KD, Begent RH, Rustin GJ, Holden L. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979-1989. Br J Obstet Gynaecol 1991; 98: 550-7.
17. Bolis G, Bonazzi C, Landoni F, et al. EMA/CO regimen in high-risk gestational tumor (GTT). Gynecol Oncol 1988; 31: 439-4.
18. Schink JC, Sing DK, Rademaker AW, Miller DS, Lurain JR. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic high-risk gestational trophoblastic disease. Obstet Gynecol 1992; 80: 817-20.
19. Soper JT, Evans AC, Clarke-Pearson DL, Berchuck A, Rodriquez G, Hammond CB. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trphoblastic disease. Obstet Gynecol 1994; 83: 113-17.
20. Quinn M, Murray J, Friedlander M, et al. EMACO in high risk gestational trophoblastic disease - The Australian Experience. Aust NZ Obstet Gynaecol 1994; 34: 90-2.
21. Erazo A, Cervantes G, Torrecillas L, Robles J. Management of high risk trophoblastic neoplasms: experience with etoposide, methotrexate, actinomycin, cyclophosphamide, vicristine (EMA-CO) (Meeting abstract). Proc Annu Meet Am Soc Clin Oncol 1994; A844.
22. Miller JM Jr, Surwit EA, Hammond CB. Choriocarcinoma following term pregnancy. Obstet Gynecol 1979; 53: 207-12.
23. Olive DL, Lurain JR, Brewer JI. Choriocarcinoma associated with term gestation. Am J Obstet Gynecol 1984; 148: 711-16.
24. Hertz R, Lewis JL Jr, Lipsett MB. Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Am J Obstet Gynecol 1961; 82: 631-40.
25. Rustin GJS, Newlands ES, Begent RHJ, Dent J, Bagshawe KD. Weekly alternativing etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. JCO 1989; 7: 900-3.
26. Bagshawe KD. Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976; 38: 1373-5.
27. Lurain JR. Causes of treatment failure in gestational trophoblastic disease. J Reprod Med 1987; 32: 675-9.
28. Bagshawe KD, Orr AH, Rushworth AGJ. Relationship between concentrations of human chorionic gonadotrophin in plasma and cerebral spinal fluid. Nature (London) 1968; 217: 950-1.
29. Jones WB, Wagner-Reiss KM, Lewis JL Jr. Intracerebral Choriocarcinoma. Gynecol Oncol 1990; 38: 234-43.
30. Bakri YN, Subhi J, Amer M, Ezzat A, Sinner W, Twiejry A, Jabbar FA. Liver metastases of gestational trophoblastic tumor. Gynecol Oncol 1993; 48: 110-13.
31. Lewis JL Jr, Ketcham AS, Hertz R. Surgical intervention during chemotherapy of gestational trophoblastic neoplasms. Cancer 1966; 19: 1517-22.
32. Hammond CB, Weed JC Jr, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980; 136: 844-58.
33. Jones WB, Schneider J, Shapiro F, Lewis JL Jr. Treatment of resistant gestational choriocarcinoma with Taxol: A report of two cases. Gynecol Oncol 1996; 61: 126-30.